您的位置: 专家智库 > >

国家自然科学基金(81001187)

作品数:2 被引量:11H指数:2
相关作者:范宇顾林张丽娜齐立强张印春更多>>
相关机构:天津医科大学更多>>
发文基金:国家自然科学基金吴阶平医学基金更多>>
相关领域:医药卫生更多>>

文献类型

  • 2篇中文期刊文章

领域

  • 2篇医药卫生

主题

  • 2篇细胞
  • 1篇单个核细胞
  • 1篇导管
  • 1篇导管癌
  • 1篇导管内
  • 1篇导管内癌
  • 1篇粘液
  • 1篇粘液性
  • 1篇乳腺
  • 1篇乳腺导管
  • 1篇乳腺导管内
  • 1篇乳腺导管内癌
  • 1篇乳腺浸润
  • 1篇乳腺浸润性
  • 1篇乳腺浸润性导...
  • 1篇乳腺浸润性导...
  • 1篇外周
  • 1篇外周血
  • 1篇外周血单个核
  • 1篇外周血单个核...

机构

  • 1篇天津医科大学

作者

  • 1篇付丽
  • 1篇张印春
  • 1篇齐立强
  • 1篇张丽娜
  • 1篇顾林
  • 1篇范宇

传媒

  • 1篇山东医药
  • 1篇Cancer...

年份

  • 1篇2013
  • 1篇2012
2 条 记 录,以下是 1-2
排序方式:
MicroRNA and histopathological characterization of pure mucinous breast carcinoma被引量:5
2013年
Objective: Pure mucinous breast carcinoma (PMBC) is an uncommon histological type of breast cancer characterized by a large amount of mucin production. MicroRNA (miRNA) is a large class of small noncoding RNA of about 22 nt involved in the regulation of various biological processes. This study aims to identify the miRNA expression profile in PMBC. Methods: MiRNA expression profiles in 11 PMBCs were analyzed by miRNA-microarray and real-time polymerase chain reaction (PCR). Thirty-one PMBCs and 27 invasive ductal carcinoma of no special types (IDC-NSTs) were assessed by immunohistochemistry using antibodies against ER, PR-progesterone receptor, HER2, Ki-67, Bcl-2, p53, PCNA, and CK5 and 6. Results: We analyzed the miRNA expression in 11 PMBCs and corresponding normal tissues using miRNA-microarray and real-time PCR, and found that miR-143 and miR-224-5p were significantly downregulated in mucinous carcinoma tissue. Compared with IDC-NSTs, PMBC showed a significantly higher ER positive rate, lower HER-2 positive rate, and lower cell proliferation rates. Conclusions: To our knowledge, this is the first study to demonstrate the miRNA expression profile of PMBC, and our findings may lead to further understanding of this type of breast cancer.
Feng ZhouShuai LiHui-Min MengLi-Qiang QiLin Gu
关键词:MICRORNA粘液性外周血单个核细胞PCR分析
乳腺浸润性导管癌组织中Bag-1、Bcl-2、Bax的表达变化及意义被引量:6
2012年
目的观察乳腺癌浸润性导管癌(IDC)组织中Bag-1、Bcl-2、Bax的表达变化,并探讨其意义。方法采用免疫组化SP法检测85例IDC及其癌旁组织中的Bag-1、Bcl-2、Bax。结果 DC组织中Bag-1、Bcl-2、Bax阳性表达率分别为92.9%(79/85)、78.8%(67/85)、74.1%(63/85),癌旁组织中分别为58.8%(50/85)、58.8%(50/85)、67.1%(57/85)。IDC组织中Bag-1、Bcl-2阳性表达率与癌旁组织比较,P均<0.05。Bag-1表达与IDC肿瘤直径有关(P<0.05)。IDC组织中,Bag-1、Bcl-2表达呈正相关(r=0.512,P<0.05)。结论 IDC组织中Bag-1、Bcl-2高表达,二者在乳腺癌的发生发展中发挥作用。
张印春张丽娜齐立强顾林付丽范宇
关键词:B细胞淋巴瘤/白血病-2乳腺浸润性导管癌乳腺导管内癌
共1页<1>
聚类工具0